Combination of mTOR inhibitor and antipolate compound

Details for Australian Patent Application No. 2007204410 (hide)

Owner Novartis AG

Inventors O'Reilly, Terence; Lane, Heidi

Agent Davies Collison Cave

Pub. Number AU-A-2007204410

PCT Pub. Number WO2007/080124

Priority 0600618.3 12.01.06 GB; 0609914.7 18.05.06 GB; 06117276.3 14.07.06 EP

Filing date 12 January 2007

Wipo publication date 19 July 2007

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/436 (2006.01)

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/080124 Priority application(s): WO2007/080124

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007204417-Anthranilamide derivatives and their use for the control of insects and acari

2007204409-Method for determining the concentration of virus particles/virus antigens